Skip to main content
Community pharmacy news, analysis and CPD | Est. 1859
Register for free
Other C+D sites
Chemist + Druggist
Well: Pharmacy must partner with 'relevant bodies' to set its future
Speaking to C+D in an exclusive interview earlier this month (July 13), Mr Hobbs said he believes “community pharmacy
GPhC warns pharmacist over codeine linctus supply, more probes ongoing
Since July last year, the General Pharmaceutical Council (GPhC) has taken enforcement action against 36 pharmacies and
Single activity fee increases 2p to £1.29 from August
The 2p increase is based on the Pharmaceutical Services Negotiating Committee’s (PSNC) “analysis of funding delivery
CMA issues over £100m in fines after 1,110% thyroid drug price hike
The outcome of a Competition and Markets Authority’s (CMA) investigation, published today (July 29), found that Advanz
Accord vows to appeal CMA case on 10,000% hydrocortisone price hiking
The Competition and Markets Authority (CMA) issued fines yesterday (July 15) totalling more than £260 million to “
GPhC seeks ‘inspirational leader’ to replace chair Nigel Clarke
The new chair will take over the role when Mr Clarke’s term ends in spring next year, and will be required to work
High Court: GPhC FtP ‘erred in approach’ to alleged antisemitism case
The Professional Standards Authority (PSA) had lodged an appeal following concerns that the General Pharmaceutical
Nasacort Allergy nasal spray switched from P to GSL as of May
The 30 spray pack of Nasacort Allergy Relief for adults 55 micrograms/dose is “sufficiently safe to be sold on general
Pharmacists may have to supply sodium valproate in original pack
The Department of Health and Social Care (DH) published its response to the Independent Medicines and Medical Devices
MHRA reviewing chloramphenicol eye drops safety as service is scrapped
Update (July 7) The Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that the benefits of
Allevia 120mg (fexofenadine) not yet in UK despite POM to GSL switch
On December 22, 2020, the Medicines Healthcare and Regulatory Authority (MHRA) published a public assessment report
Everything pharmacy teams need to know about COVID-19
It can be tricky to keep up with the news about COVID-19. To ease the process, C+D has collected a summary of all its
GSK flags new Sensodyne Deep Repair formulation with TV and video ads
The advert, which launched this month, will run over a three-month period and aims to highlight Deep Repair’s “new and
GOPO® Joint Health Plus Ginger can help with joint health
The patented product provides dual-action joint care due to the combination of ginger extract and cultivated rose-hip,
Bramox now available in 10mg strength to aide compliance
Launched yesterday (July 12), the new presentation comes in a colour-coded single tablet, aiding compliance and quality
TePe’s interdental brushes now available in 100% recyclable packaging
Manufactured in Sweden using 100% green energy, the sustainable TePe interdental brushes come in 100% recyclable
News and features
All you need to know about COVID-19
Share your stories
Clinical advisory board
Buy Update Plus
C+D Data subscription options
C+D Data FAQs
Hints & Tips
Supporting you through COVID
You are here
What next after the Celesio sale?
By Harriet Kinloch
In this week's news blog, James Waldron looks at McKesson's purchase of Celesio and its possible impact on Lloydspharmacy and AAH
Was it helpful?
Should all pharmacists become independent prescribers?
Are public health services financially viable?
to post comments
Job of the week
Midlands, Cheshire & Dorset
Salary dependent upon experience
'Outpouring of support' for pharmacy...
Claims patients cancelled pharmacy...
'Life-saving' Asda pharmacist spots...
The pharmacist helping patients feel...
GPhC registration exam: infusion...
GPhC exam: pharmacokinetics and...
, our brand new peer-to-peer network for pharmacy professionals. Access exclusive content, events, and interact with subject matter experts and like-minded professionals.
SIGN UP FOR OUR
• C+D Daily • C+D CPD
• C+D Review • C+D Careers
• C+D Alerts • C+D Advertising
Sign up now